Granules India reports 23 percent rise in Q3 profit Ruchika Sharma25 Jan 2023 3:15 PM ISTGranules, which also makes anti-inflammatory drug Ibuprofen, said 45.6 percent of its revenue came from finished dosages, the final...
Granules Pharma bags USFDA nod for ADHD drug Amphetamine Mixed Salts ER Ruchika Sharma24 Jan 2023 12:02 PM ISTMixed Salts of a Single-Entity Amphetamine ER Capsules are indicated for the treatment of Attention Deficit Hyperactivity Disorder (ADHD).
USFDA issues 3 observations for Granules India Gagillapur facility Ruchika Sharma16 Jan 2023 2:30 PM ISTHyderabad: Granules India has recently announced that US Food and Drug Administration (USFDA) has concluded Pre-Approval Inspection (PAI) with three...
Granules India, Greenko ZeroC ink pact to enable carbon free energy, green molecule solutions Ruchika Sharma3 Jan 2023 1:00 PM ISTThis collaboration allows utilization of Fungible Carbon Offset instruments across Granules global manufacturing locations.
Granules India net profit up 80 percent at Rs 145 crore in Q2 Ruchika Sharma22 Oct 2022 11:29 AM ISTBengaluru: Pharmaceutical company Granules India Ltd reported an 80% surge in quarterly profit on Thursday, boosted by higher sales of the painkiller...
Granules India Diarrhea medicine gets USFDA okay Ruchika Sharma31 Aug 2022 11:00 AM ISTLoperamide Hydrochloride and Simethicone Tablets are indicated to relieve symptoms of diarrhea plus bloating, pressure and cramps, commonly referred...
Granules Pharma US facility gets 6 observations from USFDA Ruchika Sharma23 July 2022 3:57 PM ISTNew Delhi: Drug firm Granules India today announced that the US Food and Drug Administration (USFDA) has issued six observations after the...
Granules India Receives Licences from MPP to Market generic of Pfizers Paxlovid MD Bureau21 March 2022 11:46 AM ISTThe product will be made at Granules manufacturing facilities in India that are approved by global regulatory agencies including USFDA. The license...
USFDA issues 3 minor observations to Granules India arm in pre-approval inspection MD Bureau4 March 2022 12:38 PM ISTCommenting on the audit, GPI Executive Director Priyanka Chigurupati said, "We are glad to have completed yet another audit with minor observations...
USFDA okays Granules Pharma Bupropion Hydrochloride ER Tablets Ruchika Sharma4 Feb 2022 12:43 PM ISTHyderabad: Granules India Limited has recently announced that the US Food & Drug Administration (USFDA) has approved the Abbreviated New Drug...
Granules India arm gets 3 USFDA observations for Chantilly facility Ruchika Sharma31 Jan 2022 1:02 PM ISTHyderabad: Granules India Limited announced that Granules Pharmaceuticals, Inc. (GPI), a wholly-owned foreign subsidiary of the company, located in...
Granules India secures USFDA nod for Potassium Chloride for Oral Solution Ruchika Sharma28 Jan 2022 4:16 PM ISTHyderabad: Granules India Limited announced today that the US Food & Drug Administration (USFDA) has approved the Abbreviated New Drug...
